review Open AccessTop 1% cited
mRNA vaccines — a new era in vaccinology
Nature Reviews Drug Discovery · 2018 · Vol. 17(4) · pp. 261–279
Norbert Pardi✉(University of Pennsylvania)Michael J. Hogan(University of Pennsylvania)Frederick Porter(Duke University)Drew Weissman(University of Pennsylvania)
RNA Interference and Gene DeliveryImmunotherapy and Immune ResponsesAnimal Virus Infections StudiesComputational biologyCancer vaccineMessenger RNAMedicineBiotechnologyBiologyRisk analysis (engineering)Computer scienceImmunologyImmune system
MeSH terms
VaccinologyAnimalsHumansNeoplasmsRNA, MessengerVaccines
Funding
- Bill and Melinda Gates Foundation
- National Institutes of Health
- Defense Advanced Research Projects Agency
- Advanced Research Projects Agency
- National Institute of Allergy and Infectious Diseases
Citations
4,317
FWCI
120.28
field-weighted impact
References
221
Percentile
100%
vs. same field & year
Citations per year
Cited by
Addressing the Cold Reality of mRNA Vaccine Stability
Journal of Pharmaceutical Sciences · 2020 · 496 citations
New Vaccine Technologies to Combat Outbreak Situations
Frontiers in Immunology · 2018 · 588 citations
mRNA vaccines manufacturing: Challenges and bottlenecks
Vaccine · 2021 · 488 citations
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Frontiers in Microbiology · 2021 · 883 citations
Delivery technologies for cancer immunotherapy
Nature Reviews Drug Discovery · 2019 · 2,556 citations
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
International Journal of Pharmaceutics · 2021 · 1,403 citations
Advances in mRNA Vaccines for Infectious Diseases
Frontiers in Immunology · 2019 · 675 citations
Analytical characterization of liposomes and other lipid nanoparticles for drug delivery
Journal of Pharmaceutical and Biomedical Analysis · 2020 · 364 citations
References
Stability of Endogenous and Added RNA in Blood Specimens, Serum, and Plasma
Clinical Chemistry · 2002 · 618 citations
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
Journal of Controlled Release · 2015 · 999 citations
mRNA-based therapeutics — developing a new class of drugs
Nature Reviews Drug Discovery · 2014 · 2,333 citations
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
Immunity · 2005 · 2,527 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.